A clinical trial provides encouraging results on ivermectin for reducing mild COVID-19

(Barcelona Institute for Global Health (ISGlobal)) Results show a trend to lower viral loads and shorter duration of certain symptoms among treated patients, as compared to the placebo group
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news